newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023

SAN DIEGO, June 1, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc.® (NASDAQ:MRTX), a commercial stage biotechnology company, will participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023 on June